Wells Fargo Initiates Coverage On Versigent with Overweight Rating, Announces Price Target of $35

Benzinga Newsdesk www.benzinga.com Neutral 59.1%

Neg 0% Neu 59.1% Pos 0%

Wells Fargo analyst Colin Langan initiates coverage on Versigent (NYSE:VGNT) with a Overweight rating and announces Price Target of $35.